Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.24
Delayed Data
As of 4:02pm ET
 -0.09 / -0.59%
Today’s Change
13.00
Today|||52-Week Range
101.40
+4.96%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Papa Joseph C
Chairman & Chief Executive Officer
Buy6/10/2016202,000$24.48$4.9M-36.87%
Schiller Howard Bradley
Chairman & Chief Executive Officer
Sale2/18/201651,846$91.45$4.7M-83.81%
Kellen Ari
Chairman
Sale12/05/201619,932$18.00$358.8K-0.65%
Kellen Ari
Chairman
Sale1/26/20163,317$88.98$295.1K-84.54%
Rosiello Robert L
Executive VP-Corporate Development & Strategy
Sale12/05/201614,687$18.00$264.4K-0.65%
Schiller Howard Bradley
Chairman & Chief Executive Officer
Sale2/18/20162,245$91.45$205.3K-83.81%
De Schutter Richard U
Director
Gift1/03/201711,190$15.24$170.5K0.00%
Whitaker Anne C
Chairman
Sale12/05/20166,012$18.00$108.2K-0.65%
Karabelas Argeris N
Director
Buy8/11/20164,000$24.65$98.6K-37.77%
Ross Thomas W Sr
Director
Buy6/13/20164,000$24.40$97.6K-35.91%
Page of 5